Population Pharmacokinetic Analysis of Yimitasvir in Chinese Healthy Volunteers and Patients With Chronic Hepatitis C Virus Infection

Yimitasvir is a novel, oral hepatitis C virus (HCV) non-structural protein 5A inhibitor for the treatment of chronic HCV genotype 1 infection. The objective of this analysis was to develop a population pharmacokinetic model of yimitasvir in Chinese healthy volunteers and HCV infection patients. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Xiao-duo, Tang, Xian-ge, Zhang, Ying-jun, Xie, Hong-ming, Luo, Lin, Wu, Dan, Chen, Rui, Hu, Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876056/
https://www.ncbi.nlm.nih.gov/pubmed/33584296
http://dx.doi.org/10.3389/fphar.2020.617122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876056/
https://www.ncbi.nlm.nih.gov/pubmed/33584296
http://dx.doi.org/10.3389/fphar.2020.617122

Ejemplares similares